Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug 1;60(15):2521.
doi: 10.2169/internalmedicine.6952-20. Epub 2021 Feb 15.

Reply to "Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?"

Hiroaki Matsuura  1 , Keiichi Fujiwara  1 , Hiroki Omori  1 , Kiriko Onishi  1 , Tadahiro Kuribayashi  1 , Sho Mitsumune  1 , Yuki Takigawa  1 , Kenichiro Kudo  1 , Akiko Sato  1 , Ken Sato  1 , Takuo Shibayama  1
Affiliations
Comment

Reply to "Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?"

Hiroaki Matsuura et al. Intern Med. .
No abstract available

Keywords: allergic bronchopulmonary aspergillosis; benralizumab; bronchial asthma; triazole antifungal.

PubMed Disclaimer

Comment on

References

    1. Matsuura H, Fujiwara K, Omori H, et al. Successful treatment with benralizumab for allergic bronchopulmonary aspergillosis that developed after disastrous heavy rainfall in Western Japan. Intern Med 60: 1443-1450, 2021. - PMC - PubMed
    1. Agarwal R, Dhooria S, Sehgal IS, et al. A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Eur Respir J 52: 1801159, 2018. - PubMed
    1. Agarwal R, Dhooria S, Sehgal IS, et al. A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Chest 153: 656-664, 2018. - PubMed
    1. Moreira AS, Silva D, Ferreira AR, Delgado L. Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review. Clin Exp Allergy 44: 1210-1227, 2014. - PubMed
    1. Chupp G, Lugogo NL, Kline JN, et al. Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma. Ann Allergy Asthma Immunol 122: 478-485, 2019. - PubMed

MeSH terms

Substances